Yuwaye Chu Net Worth & Insider Trades

Yuwaye Chu - Chief Medical Officer, Fate Therapeutics Inc

As of April 21, 2022

What is Yuwaye Chu's Net Worth?

The current estimated net worth of Fate Therapeutics Inc's Chief Medical Officer, Yuwaye Chu, is estimated to be about $2.51M . Yuwaye Chu owns about 151,033 units of Fate Therapeutics Inc common stock. In the last year at Fate Therapeutics Inc, Yuwaye Chu has sold an estimated value of $994.77K worth.

What is Yuwaye Chu's Past Insider Trading?

Yuwaye Chu's largest purchase order was 7,500 units , worth over $122.4K on December 13, 2021. Yuwaye Chu's largest sale order was 7,500 units , worth over $385.95K on December 13, 2021. In total, Yuwaye Chu has made about 6 transactions over a year of their time at Fate Therapeutics Inc. Yuwaye Chu usually trades in January and April, with the busiest year in 2022 and 2021. The most recent transaction was a sale order of 4,062 units , worth over $143.67K on April 21, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Yuwaye Chu's' Mailing Address?

  • Mailing address is Fate Therapeutics, Inc. 3535 General Atomics Court Ste 200 San Diego CA 92121 CA

Fate Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
J. Scott Wolchko 2020 $570,000 - $1,451,340 $3,222,577 $356,250 - $5,600,167
J. Scott Wolchko 2019 $540,000 - $4,137,500 $5,732,955 $310,500 - $10,720,955
J. Scott Wolchko 2018 $516,000 - - $2,756,998 $258,000 - $3,530,998
Edward J. Dulac III 2020 $142,500 $137,917 $1,420,800 $3,786,529 $75,833 $120,000 $5,683,579
Bahram Valamehr, Ph.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Bahram Valamehr, Ph.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Bahram Valamehr, Ph.D. 2018 $321,865 - - $2,138,235 $117,250 - $2,577,350
Cindy R. Tahl, J.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Cindy R. Tahl, J.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Cindy R. Tahl, J.D. 2018 $350,000 - - $906,465 $122,500 - $1,378,965
Daniel D. Shoemaker, Ph.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Daniel D. Shoemaker, Ph.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Daniel D. Shoemaker, Ph.D. 2018 $365,000 - - $842,338 $127,750 - $1,335,088
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1434316/000119312521124699/d85377ddef14a.htm

What are Fate Therapeutics Inc's Past Insider Trades?

Fate Therapeutics Inc's most recent insider trade came on July 25, 2022 by Scott Wolchko who sold 36,246 units worth $1.19M . In the last 9 years, insiders at Fate Therapeutics Inc have sold an estimated value of $126.38M and bought an estimated value of $170.91M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Scott Wolchko, President and CEO,  Cindy Tahl, General Counsel and Secretary,  and Amir Nashat, Director .

FATE THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1